Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Phillip Grovenstein

2PUBLICATIONS

7CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsInnate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Mar 12, 2025

Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered.

Phillip Grovenstein, Noopur Bhatnagar, Ki-Hye Kim

|Jul 29, 2023

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination.

Noopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah

Pageof 1

Frequent Collaborators

2 joint publications

Noopur Bhatnagar

1 joint publications

Bao-Zhong Wang

1 joint publications

Sang-Moo Kang

1 joint publications

Chau Thuy Tien Le

1 joint publications

Chong Hyun Shin

1 joint publications

Lanying Du

1 joint publications

Jeeva Subbiah

Frequent Collaborators

2 joint publications

Noopur Bhatnagar

1 joint publications

Bao-Zhong Wang

1 joint publications

Sang-Moo Kang

1 joint publications

Chau Thuy Tien Le

Top Related Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on : Jun 25, 2015

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos

Top Related Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on : Jun 25, 2015

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos